Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke? A double-blind randomized clinical trial

Journal of Rehabilitation Medicine

Volumn 39, Issue 6, 2007, Pages 440-447

  Marco, Ester ^a   Duarte, Esther ^a   Villa, Joan ^c   Tejero, Marta ^a   Guillen, Anna ^a   Boza, Roser ^a   Escalada, Ferran ^a   Espadaler, Josep M ^b  

^a HOSPITAL DE L ESPERANÇA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

Botulinum toxin; Cerebrovascular disease; Muscle spasticity; Rehabilitation; Shoulder pain

Indexed keywords

BOTULINUM TOXIN A; PLACEBO;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MALE; PHYSICAL MOBILITY; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; SHOULDER PAIN; SPAIN; SPASTICITY; TRANSCUTANEOUS NERVE STIMULATION; VISUAL ANALOG SCALE;

ADULT; AGED; BOTULINUM TOXIN TYPE A; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEMIPLEGIA; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; PAIN MEASUREMENT; RANGE OF MOTION, ARTICULAR; SHOULDER PAIN; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; TREATMENT OUTCOME;

EID: 34447577981     PISSN: 16501977     EISSN: None     Source Type: Journal    
DOI: 10.2340/16501977-0066     Document Type: Article

References (33)

1. Joynt RL. The source of shoulder pain in hemiplegia. Arch Phys Med Rehabil 1992; 73: 409-413.
2. Van Ouwenaller C, Laplace PM, Chantraine A. Painful shoulder in hemiplegia. Arch Phys Med Rehabil 1986; 67: 23-26.
3. Zorowitz RD, Hughes MB, Idank D, Ikai T, Johnston MV. Shoulder pain after subluxation after stroke: correlation or coincidence? Am J Occup Ther 1996; 50: 194-201.
4. Abruzzesse G. The medical management of spasticity. Eur J Neurol 2002; 9: 30-34.
5. Chantraine A, Baribeault A, Uebelhart D, Gremion G. Shoulder pain and dysfunction in hemiplegia: effects of functional electrical stimulation. Arch Phys Med Rehabil 1999; 80: 328-331.
6. Leandry M, Bouter LM, Beckerman H. Comparison of TENS treatments in hemiplegic shoulder pain. Scand J Rehabil Med 1990; 22: 69-71.
7. Sonde L, Geip F, Fernaeus SE, Nilsson CG, Viitanen M. Stimulation with low frequency (1.7 Hz) transcutaneous electric nerve stimulation (low TENS) increases motor function of the post-stroke paretic arm. Scand J Rehabil Med 1998; 30: 95-99.
8. Petrillo CR, Chu DS, Davis SW. Phenol block of the tibial nerve in the hemiplegic patient. Orthopedics 1980; 3: 871-874.
9. Zafonte RD, Munin MC. Phenol and alcohol blocks for the treatment of spasticity. Phys Med Rehabil Clin N Am 2001; 12: 817-832.
10. Das TK, Park DM. Effect of treatment with botulinum toxin on spasticity. Postgrad Med J 1989; 65: 208-210.
11. Snow BJ, Tsui JKC, Bhatt MH, Varelas M, Hashimoto SA, Calne DB. Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol 1990; 28: 512-515.
12. Yablon SA. Botulinum toxin A: experience in the management of spasticity among patients with traumatic brain injury. Eur J Neurol 1995; 2: 47-55.
13. Koman LA, Mooney JF, Smith BP. Botulinum toxin: potential role in the management of cerebral palsy during childhood. In: Janovic J, Hallet M, editors. Therapy with botulinum toxin. New York: Marcel Dekker; 1994, pp. 511-522.
14. Cosgrove AP, Graham HK. Botulinum Toxin A in the management of spasticity with cerebral palsy. Br J Surg 1992; 74B: 135-136.
15. Dykstra DD, Sidi AA: Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study. Arch Phys Med Rehabil 1990; 71: 24-26.
16. Grazko MA, Polo KB, Jabbari B. Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology 1995; 45: 712-717.
17. Das TK, Park DM: Botulinum toxin in treating spasticity. Br J Clin Pract 1989; 43: 401-403.
18. Simpson DM, Alexander DN, O'Brien CF, Tagliati M, Aswad AS, Leon JM, et al. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 1996; 46: 1306-1310.
19. Van Kuijk AA, Geurts ACH, Bevaart BJW, van Limbeek J. Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: a systematic review of the literature. J Rehabil Med 2002; 12: 51-61.
20. Yelnik AP, Colle FM, Bonan IV. Treatment of pain and limited movement of the shoulder in hemiplegic patients with botulinum toxin A in the subescapular muscle. Eur Neurol 2003; 50: 91-93.
21. Bohannon RW, Smith MB. Interrater reliability of a Modified Ashworth Scale of Muscle Spasticity. Phys Ther 1987; 67: 206-207.
22. Brunnstrom S, editor. Movement therapy in hemiplegia: a neurophysiological approach. Hagerstown, MD: HarpeRow; 1970.
23. Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity scale: what is moderate pain in millimetres? Pain 1997; 72: 95-97.
24. Erickson RP, McPhee MC. Clinical evaluation. In: DeLisa JA, Gans BM, editors. Rehabilitation medicine: principles and practice, 3rd edn. Philadelphia: Lippincott-Raven Publishers; 1998, p. 74-75.
25. Voller B, Sycha T, Gustorff B, Schmetterer L, Lehr S, Eichler HG, et al. A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A. Neurology 2003; 61: 940-944.
26. Dengler R, Neyer U, Wohlfarth K, Betting U, Janzik H. Local botulinum toxin in the treatment of spastic foot drop. J Neurol 1992; 239: 375-378.
27. Dunne JW, Heye N, Dunne SL. Treatment of chronic limb spasticity with botulinum toxin A. J Neurol Neurosurg Psychiatry 1995; 58: 232-235.
28. Foster L, Clapp L, Erickson M, Jabbari B. Botulinum toxin A and chronic low back pain: a randomized, double-blind study. Neurology 2001; 56: 1290-1293.
29. Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 2000, 85: 101-105.
30. Rosales RL, Arimura K, Takenaga S, Osame M. Extrafusal and intrafusal muscle effects in experimental botulinum toxin type A injection. Muscle Nerve 1996; 19: 488-496.
31. Brin MF, Aoki KR. Botulinum toxin type A: Pharmacology. In: Mayer NH, Simpson DM, editors. Spasticity: etiology, evaluation, management and the role of botulinum toxin. New York: WE Move; 2002, p. 110-125.
32. Chironna RL, Hecht JS. Subscapularis motor point block for the painful hemiplegic shoulder. Arch Phys Med Rehabil 1990; 71: 428-429.
33. Hecht JS. Subscapular nerve block in the painful hemiplegic shoulder. Arch Phys Med Rehabil 1992; 73: 1036-1039.